Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2025-12-24 @ 9:44 PM
NCT ID:
NCT02450032
Eligibility Criteria:
Inclusion Criteria:
* Patients with histologically confirmed UICC Stage I, II or III gastric adenocarcinoma.
* Patients must have had a macroscopically curative resection for gastric cancer with absence of metastatic disease at the time of entry to the trial.
* Male or Female patients aged 18 years or older.
* Life expectancy of at least 3 months.
* WHO Performance Status of 0 to 1.
* Written informed consent
Exclusion Criteria:
* Gastric surgery within four weeks of baseline (Week 0, visit 2) or gastric surgery anticipated during the period of the study.
* History of other malignant disease within the previous five years, except nonmelanomatous skin cancer or in situ carcinoma of the uterine cervix.
* Previous use within the last four weeks, concomitant use of anticipated use in the period of study, of any anti-cancer therapies.
* Concomitant use of immunosuppressants, including systemic (i.e. oral or injected) corticosteroids.
* Females who were pregnant, planning to become pregnant or lactating.
* Patients taking part in another study involving an investigational or licensed drug or device in the three months preceding enrollment or during this study.
* Previous G17DT treatment.
* Haematologicial indicators:
Haemoglobin (Hb) \< 10g/dL White blood cell count (WBC) \< 4.0 x 10\^9/L Platelets \< 100 x 10\^9/L
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02450032
Study Brief:
Protocol Section:
NCT02450032